Health and Healthcare
Health and Healthcare Articles
The December 31 short interest data has been compared with the previous report, and short interest in these selected biotech stocks increased.
Published:
Last Updated:
Here are 20 biotechnology and pharmaceutical stocks that have been given big analyst upside targets for 2020.
Published:
Last Updated:
Dermira shares made a handy gain to close out the week after it was announced that Eli Lilly would be acquiring the firm.
Published:
Last Updated:
Applied Genetic Tech shares jumped by more than 50% on Thursday after the firm announced positive interim data from its midstage trial in X-linked retinitis pigmentosa.
Published:
DBV Tech shares jumped on Thursday after the firm announced positive topline results from its late-stage study in children with a peanut allergy.
Published:
Here are 11 biotech and pharma stocks that have been given big analyst upside targets for 2020.
Published:
Last Updated:
Xeris Pharmaceuticals shares pushed higher on Tuesday after the firm announced positive topline results from its midstage study in adults with Type 1 diabetes mellitus.
Published:
Apellis Pharmaceuticals shares jumped on Tuesday after the firm announced positive results from its late stage study in adults with paroxysmal nocturnal hemoglobinuria (PNH). Specifically, the data...
Published:
On a company by company basis, investing in biotechs is somewhat tricky. However, there is an investment strategy that makes it much easier.
Published:
Last Updated:
Ahead of election years, the cost and future of health care has become one of the top debates for better than two decades now. Most politicians say that they want to lower prescription drug costs....
Published:
Last Updated:
Here, 24/7 Wall St. presents a calendar of a few of the biggest clinical trial and FDA updates to watch for in early 2020.
Published:
Last Updated:
Innate Pharma shares jumped on Thursday after the firm announced that the European Medicines Agency has accepted the Marketing Authorization Application for Lumoxiti for adult patients with relapsed...
Published:
Neovasc shares nearly doubled on Tuesday after the firm announced the submission of an application to the FDA for its Neovasc Reducer medical device for the treatment of refractory angina.
Published:
Wave Life Sciences shares dropped sharply to start out the week after the company announced topline data from its ongoing midstage trial in Huntington’s disease.
Published:
Sarepta shares jumped last week on news that the company reached a licensing deal with Roche. While investors saw about a five-point bump from this news, one analyst sees much more upside for this...
Published:
Last Updated:
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.